High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.6M
$1,631,254
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
IONS
S
IONIS PHARMACEUTICALS INC
Schneider Eugene
• Officer • EVP, Chf Clinical Develop Ofcr
10b5-1 Sell
2026-03-19
$412,486
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf Clinical Develop Ofcr
10b5-1 Sell
|
2026-03-19 | $412,486 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Schneider Eugene
• Officer • EVP, Chf Clinical Develop Ofcr
Discretionary Sell
2026-01-30
$515,630
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf Clinical Develop Ofcr
Discretionary Sell
|
2026-01-30 | $515,630 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Schneider Eugene
• Officer • EVP, Chf Clinical Develop Ofcr
Sell to CoverΔOwn -12.7%
2026-01-16
$703,138
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf Clinical Develop Ofcr
Sell to CoverΔOwn -12.7%
|
2026-01-16 | $703,138 | S | Form 4 |